Wells Fargo’s CapForce IBD 50 ETF FFTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.9K | Buy |
+250
| New | +$9.85K | ﹤0.01% | 6054 |
|
|
2026
Q1 | – | Hold |
0
| – | – | – | 6938 |
|
|
2025
Q4 | – | Sell |
-39
| Closed | -$1.44K | – | 7062 |
|
|
2025
Q3 | $1.45K | Buy |
39
+38
| +3,800% | +$1.31K | ﹤0.01% | 6226 |
|
|
2025
Q2 | $48 | Sell |
1
-405
| -100% | -$11.6K | ﹤0.01% | 6588 |
|
|
2025
Q1 | $11K | Sell |
406
-4,775
| -92% | -$140K | ﹤0.01% | 5867 |
|
|
2024
Q4 | $148K | Sell |
5,181
-2,718
| -34% | -$79.1K | ﹤0.01% | 4971 |
|
|
2024
Q3 | $212K | Sell |
7,899
-3,597
| -31% | -$94.7K | ﹤0.01% | 4530 |
|
|
2024
Q2 | $319K | Sell |
11,496
-2,888
| -20% | -$78.7K | ﹤0.01% | 4201 |
|
|
2024
Q1 | $398K | Buy |
14,384
+1,639
| +13% | +$42.8K | ﹤0.01% | 4041 |
|
|
2023
Q4 | $311K | Sell |
12,745
-7,356
| -37% | -$167K | ﹤0.01% | 4188 |
|
|
2023
Q3 | $450K | Sell |
20,101
-5,335
| -21% | -$129K | ﹤0.01% | 3852 |
|
|
2023
Q2 | $651K | Sell |
25,436
-2,625
| -9% | -$62.2K | ﹤0.01% | 3760 |
|
|
2023
Q1 | $663K | Buy |
28,061
+3,611
| +15% | +$82.9K | ﹤0.01% | 3654 |
|
|
2022
Q4 | $533K | Sell |
24,450
-8,556
| -26% | -$211K | ﹤0.01% | 3601 |
|
|
2022
Q3 | $807K | Sell |
33,006
-4,280
| -11% | -$118K | ﹤0.01% | 3377 |
|
|
2022
Q2 | $1M | Sell |
37,286
-17,059
| -31% | -$548K | ﹤0.01% | 3292 |
|
|
2022
Q1 | $2.12M | Sell |
54,345
-22,574
| -29% | -$876K | ﹤0.01% | 3237 |
|
|
2021
Q4 | $3.53M | Buy |
76,919
+3,326
| +5% | +$159K | ﹤0.01% | 2922 |
|
|
2021
Q3 | $3.49M | Buy |
73,593
+684
| +0.9% | +$32K | ﹤0.01% | 3184 |
|
|
2021
Q2 | $3.38M | Buy |
72,909
+3,167
| +5% | +$143K | ﹤0.01% | 3227 |
|
|
2021
Q1 | $3.06M | Sell |
69,742
-40,995
| -37% | -$1.86M | ﹤0.01% | 3314 |
|
|
2020
Q4 | $4.55M | Buy |
110,737
+10,412
| +10% | +$406K | ﹤0.01% | 2845 |
|
|
2020
Q3 | $3.74M | Buy |
100,325
+3,676
| +4% | +$135K | ﹤0.01% | 2774 |
|
|
2020
Q2 | $3.33M | Sell |
96,649
-56,467
| -37% | -$1.75M | ﹤0.01% | 2839 |
|
|
2020
Q1 | $4.29M | Sell |
153,116
-116,163
| -43% | -$3.87M | ﹤0.01% | 2362 |
|
|
2019
Q4 | $9.35M | Sell |
269,279
-129,882
| -33% | -$4.39M | ﹤0.01% | 2009 |
|
|
2019
Q3 | $12.9M | Sell |
399,161
-299,657
| -43% | -$10.2M | ﹤0.01% | 1758 |
|
|
2019
Q2 | $24M | Sell |
698,818
-268,432
| -28% | -$9.05M | 0.01% | 1358 |
|
|
2019
Q1 | $32.4M | Buy |
967,250
+635,726
| +192% | +$20M | 0.01% | 1146 |
|
|
2018
Q4 | $9.16M | Sell |
331,524
-91,187
| -22% | -$2.83M | ﹤0.01% | 1918 |
|
|
2018
Q3 | $16.2M | Buy |
422,711
+291,144
| +221% | +$10.7M | ﹤0.01% | 1680 |
|
|
2018
Q2 | $4.62M | Buy |
131,567
+123,207
| +1,474% | +$4.3M | ﹤0.01% | 2763 |
|
|
2018
Q1 | $279K | Hold |
8,360
| – | – | ﹤0.01% | 4781 |
|
|
2017
Q4 | $277K | Hold |
8,360
| – | – | ﹤0.01% | 4795 |
|
|
2017
Q3 | $264K | Hold |
8,360
| – | – | ﹤0.01% | 4764 |
|
|
2017
Q2 | $227K | Hold |
8,360
| – | – | ﹤0.01% | 4696 |
|
|
2017
Q1 | $214K | Hold |
8,360
| – | – | ﹤0.01% | 4769 |
|
|
2016
Q4 | $202K | Hold |
8,360
| – | – | ﹤0.01% | 4777 |
|
|
2016
Q3 | $197K | Hold |
8,360
| – | – | ﹤0.01% | 4493 |
|
|
2016
Q2 | $180K | Buy |
+8,360
| New | +$176K | ﹤0.01% | 4464 |
|
Other funds holding FFTY
IWM
DSCM
CPIG
CFP
Wells Fargo's FFTY Position: Q2 2026 in Review
Wells Fargo opened a new position in CapForce IBD 50 ETF (FFTY) in Q2 2026: 250 shares worth $10.9K. The stake represents ﹤0.01% of the portfolio and ranks #6054 among its holdings. This is a return to the name: Wells Fargo previously reported a position in FFTY as recently as Q3 2025.
Wells Fargo first reported a position in FFTY in Q2 2016 and has held it in 39 quarters since. The position peaked at $32.4M in Q1 2019. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.
- Wells Fargo held 250 shares of CapForce IBD 50 ETF worth $10.9K as of Q2 2026.
- CapForce IBD 50 ETF was a new Wells Fargo position in Q2 2026.
- CapForce IBD 50 ETF made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6054 holding.
- Wells Fargo first reported a position in CapForce IBD 50 ETF in Q2 2016 and has held it in 39 quarters since.
- Wells Fargo's CapForce IBD 50 ETF position peaked at $32.4M in Q1 2019.
- 33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.